DIACEUTICS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 131 GBX | -0.38% |
|
+1.16% | +50.57% |
| Jun. 12 | Transcript : Diaceutics PLC - Analyst/Investor Day | |
| Jun. 07 | YouGov brings Diaceutics Chair Deborah Davis onto board | AN |
Presenter SpeechSimon Geelon (Attendees)Good afternoon, and welcome to today's Capital Markets...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Diaceutics PLC is a United Kingdom-based company, which is a provider of technology and solutions. The Company provides pharma and biotech companies with an end-to-end commercialization solution for precision medicine through data analytics, scientific and advisory services enabled by its platform DXRX - The Diagnostics Network. The Company operates through three segments: Insight Solutions (Data), Engagement Solutions (Tech enabled services), and Advisory Services (Professional services). The Companyâs DXRX - The Diagnostics Network is a diagnostic commercialization platform for precision medicine, integrating multiple pipelines of real-world diagnostic testing data from a global network of laboratories. It provides unrivalled access to multiple pipelines of real-world diagnostic testing data from a global network of laboratories. Its Tech Enabled Services offers clinical testing labs to provide enablement and educational services in novel biomarkers.
Sector
Business Support Services
Calendar
2024-09-08
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.31
GBP
Average target price
1.726
GBP
Spread / Average Target
+31.76%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +50.57% | 144M | |
| +23.01% | 4.72B | |
| -14.49% | 2.58B | |
| +53.42% | 2.4B | |
| +16.59% | 1.84B | |
| -14.12% | 1.51B | |
| -28.96% | 1.35B | |
| -28.72% | 1.26B | |
| -16.70% | 1.05B | |
| -34.79% | 715M |
- Stock Market
- Equities
- DXRX Stock
- News Diaceutics PLC
- Transcript : Diaceutics PLC - Analyst/Investor Day
